Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v2.4.0.8
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Revenues        
Product $ 2,450 $ 2,655 $ 8,627 $ 10,312
Product licensing fees 629 702 1,459 1,125
Service 214 183 668 680
Total revenues 3,293 3,540 10,754 12,117
Cost of revenues        
Product 1,023 906 3,247 2,986
Service 161 163 493 576
Total cost of revenues 1,184 1,069 3,740 3,562
Gross profit 2,109 2,471 7,014 8,555
Operating expenses        
Research and development 775 509 2,165 1,554
Selling, general and administrative 2,880 2,642 8,792 8,993
Total operating expenses 3,655 3,151 10,957 10,547
Loss from operations (1,546) (680) (3,943) (1,992)
Interest expense (618) (275) (1,056) (843)
Interest income 0 1 1 3
Gain (loss) due to change in fair value of common stock (See Note 3) 1,567 (864) 1,357 (864)
(Loss) gain due to change in fair value of derivative instruments 0 (84) 0 766
Other expense, net (14) (10) (81) (56)
Net loss (611) (1,912) (3,722) (2,986)
Preferred stock deemed dividend 0 0 0 (1,062)
Net loss available to common shareholders (611) (1,912) (3,722) (4,048)
Net loss per common share: basic and diluted $ (0.09) $ (0.37) $ (0.56) $ (0.85)
Weighted-average number of shares used in per common share calculations:        
Basic and diluted 6,810,000 5,126,000 6,687,000 4,767,000
Other comprehensive loss, net of tax        
Net loss (611) (1,912) (3,722) (2,986)
Foreign currency translation adjustments 8 (16) (78) (17)
Other comprehensive loss $ (603) $ (1,928) $ (3,800) $ (3,003)